Form 4 for AFRM Affirm Holdings, Inc.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001628280-24-049194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-25 | 2024-11-21+ | AFRM | O'Hare Robert | CFO | M - OptEx | $47.21 | +120.1K | 29.8K | New | +$5.67M |
| DM | 2024-11-25 | 2024-11-21+ | AFRM | O'Hare Robert | CFO | S - Sale+OE | $68.77 | -120.1K | 0 | -100% | -$8.26M |
| DM | 2024-11-25 | 2024-11-21+ | AFRM | O'Hare Robert | CFO | M - OptEx | $0.00 | -120.1K | 31.2K | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-25 | M | A | 79,039 | $49.00 | 79,039 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-11-22 | S | D | 11,218 | $70.00 | 0 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-11-22 | M | A | 11,218 | $49.00 | 11,218 | D | — | — | |
| 4 | Common | Class A Common Stock | 2024-11-21 | S | D | 29,840 | $65.01 | 0 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $65.00 to $65.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Class A Common Stock | 2024-11-21 | M | A | 29,840 | $41.80 | 29,840 | D | — | — | |
| 6 | Common | Class A Common Stock | 2024-11-25 | S | D | 79,039 | $70.01 | 0 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $70.00 to $70.19 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-11-22 | M | D | 11,218 | $0.00 | 110,282 | D | $49.00 · — to 2031-01-13 | 11,218 Class A Common Stock | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024. (F5) The stock option vests with respect to 5% of the shares of Class A Common Stock underlying the stock option on the six-month anniversary of January 1, 2021, the vesting commencement date, and the remainder of the grant will vest in quarterly installments over a period of four years, in annual aggregate amounts equal to 15%, 20%, 30% and 30%, respectively, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-11-21 | M | D | 29,840 | $0.00 | 14,922 | D | $41.80 · — to 2032-03-02 | 29,840 Class A Common Stock | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024. (F4) The stock options vest in 48 equal monthly installments beginning April 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-11-25 | M | D | 79,039 | $0.00 | 31,243 | D | $49.00 · — to 2031-01-13 | 79,039 Class A Common Stock | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024. (F5) The stock option vests with respect to 5% of the shares of Class A Common Stock underlying the stock option on the six-month anniversary of January 1, 2021, the vesting commencement date, and the remainder of the grant will vest in quarterly installments over a period of four years, in annual aggregate amounts equal to 15%, 20%, 30% and 30%, respectively, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. |